CEGEDIM 
By PRESS RELEASE
Page 1
Cegedim Strategic Data (CSD) ranks pharmaceutical companies' social media presenceParis, December 19, 2011 - Cegedim Strategic Data(CSD), leading provider of integrated healthcare market research and worldwide promotional audits, has initiated a study comparing the ranking of pharmaceutical companies' spend on traditional promotional channels to their presence on two leading social media channels - Facebook and Twitter.
The analysis of social network presence was conducted
worldwide for November 2011 focusing on the top 100
pharmaceutical companies in terms of traditional sales force
and marketing channel spending. CSD then identified the Top
30 pharmaceutical companies for Facebook
and for Twitter based on their presence and
healthcare-focused activities.
Results: Top 3 companies in traditional promotional spending
The US multinational Pfizer ranks first worldwide in
traditional promotional spending, and is also present in the
top spots for social media presence: third position for the
number of Likes on Facebook, and first for the number of
followers on Twitter.
Novartis, the Swiss multinational that ranks second in
traditional promotional spending, is somewhat behind Pfizer,
in seventeenth position for Likes on Facebook, and fifth
position on Twitter for the number of followers.
Merck & Co is in third position worldwide for traditional
promotional spending, and seems to show contrasting positions
for social media activity. The company ranks tenth on the
number of Likes on Facebook, while at the same time ranks
number one for the number of pages. On Twitter Merck & Co
ranks fifteenth for the number of followers and third for the
number of Tweets.
Other companies with a strong presence
Other companies that show a strong presence on Facebook and
Twitter for their healthcare- focused activities include:
